Engineered immunoglobulins with altered fcrn binding
MY215035AActive Publication Date: 2026-08-24UNIVERSITY OF OSLO
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2022003093
- Authority / Receiving Office
- MY · MY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-03-14
- Filing Date
- 2017-03-14
- Publication Date
- 2026-08-24
- Estimated Expiration
- 2037-03-14
Abstract
The present invention relates to compositions and methods for antibody-mediated therapy. In particular, provided herein are engineered immunoglobulins with altered half-life.
Need to check novelty before this filing date? Find Prior Art